@article{8a78e17bb6564c5ba5d5be0d07eab584,
title = "Treatment of older patients with mantle-cell lymphoma",
abstract = "The long-term prognosis for older patients with mantle-cell lymphoma is poor. Chemoimmunotherapy results in low rates of complete remission, and most patients have a relapse. We investigated whether a fludarabine-containing induction regimen improved the complete-remission rate and whether maintenance therapy with rituximab prolonged remission.",
keywords = "Aged, Aged, 80 and over, Antibodies, Monoclonal, Murine-Derived, Antineoplastic Combined Chemotherapy Protocols, Cyclophosphamide, Doxorubicin, Female, Humans, Induction Chemotherapy, Intention to Treat Analysis, Lymphoma, Mantle-Cell, Maintenance Chemotherapy, Male, Middle Aged, Prednisone, Prospective Studies, Remission Induction, Survival Rate, Vidarabine, Vincristine",
author = "Kluin-Nelemans, \{H C\} and E Hoster and O Hermine and J Walewski and M Trneny and Geisler, \{C H\} and S Stilgenbauer and C Thieblemont and U Vehling-Kaiser and Doorduijn, \{J K\} and B Coiffier and R Forstpointner and H Tilly and L Kanz and P Feugier and M Szymczyk and M Hallek and S Kremers and G Lepeu and L Sanhes and Zijlstra, \{J M\} and R Bouabdallah and Lugtenburg, \{P J\} and M Macro and M Pfreundschuh and V Proch{\'a}zka and \{Di Raimondo\}, F and V Ribrag and M Uppenkamp and M Andr{\'e} and W Klapper and W Hiddemann and M Unterhalt and Dreyling, \{M H\}",
year = "2012",
doi = "10.1056/NEJMoa1200920",
language = "English",
volume = "367",
pages = "520--31",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "6",
}